MDV Management Company’s Adamas Pharmaceuticals ADMS Stock Holding History

MDV Management Company’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$79.6M	Buy	+4,584,014	New	+$69.6M	26.88%	2

Other funds holding ADMS

CPH

C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

MDV Management Company's ADMS Position: Q4 2014 in Review

MDV Management Company opened a new position in Adamas Pharmaceuticals (ADMS) in Q4 2014: 4,584,014 shares worth $79.6M. The stake represents 26.88% of the portfolio and ranks #2 among its holdings.

52 funds tracked by Wall St. Rank hold ADMS as of Q4 2014.

MDV Management Company held 4,584,014 shares of Adamas Pharmaceuticals worth $79.6M as of Q4 2014.
Adamas Pharmaceuticals was a new MDV Management Company position in Q4 2014.
Adamas Pharmaceuticals made up 26.88% of MDV Management Company's portfolio in Q4 2014, its #2 holding.
52 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2014.

Based on MDV Management Company's 13F filing for Q4 2014, filed 17 Feb 2015.